Video | Business Headlines | Internet | Science | Scientific Ethics | Technology | Search

 

Future of NZ's clinical research under microscope


Future of New Zealand's clinical research under the microscope

GlaxoSmithKline is launching what it hopes will only be the start of annual clinical research forums in New Zealand.

The inaugural National Clinical Trials Seminar is being held on Saturday 1 November at the Heritage Hotel, Hobson Street, Auckland, from 9am to 4pm.

Topics will include the trans-Tasman agreement, the role of DHBs in clinical research, Maori consultation, ethics committees, indemnity and compensation.

"The symposium is open to anybody with an interest in clinical research including clinicians, research nurses, general nurses and the pharmaceutical industry," GlaxoSmithKline medical director Dr Ian Griffiths says.

The idea for a New Zealand clinical research forum came from GSK's clinical research team. The team attended the Australian Clinical Research Symposium last year and found the experience extremely valuable. It also sparked the idea to hold a similar event here celebrating New Zealand research.

GlaxoSmithKline invests the equivalent of NZ $8 billion annually in clinical research around the world and in addition to being involved with the international research GSK New Zealand has also invested $8 million in clinical research right here. This research includes asthma, looking at the effects of the company's latest type 2 diabetes medication on cardiovascular disease in type 2 diabetes patients, research looking at combination treatment for chronic obstructive pulmonary disease (COPD) and studies looking at the prevention of prostate cancer and treatment of atrial fibrillation.

It is for this reason the clinical research team believes an annual symposium will provide a valuable and exciting platform for New Zealand's clinical researchers to come together, Dr Griffiths says. "The company believes this is an important enough initiative to take a lead and organise the first event. However, it is hoped others will take on the organisation of future forums, and that the forums will become an annual event."

The deadline for registration is the end of September. Registration forms can be accessed on the GlaxoSmithKline website www.gsk-conferences.co.nz

© Scoop Media

 
 
 
Business Headlines | Sci-Tech Headlines

 

Voluntary Administration: Renaissance Brewing Up For Sale

Renaissance Brewing, the first local company to raise capital through equity crowdfunding, is up for sale after cash flow woes and product management issues led to the appointment of voluntary administrators. More>>

Elsewhere:

Approval: Northern Corridor Decision Released

The approval gives the green light to construction of the last link of Auckland’s Western Ring Route, providing an alternative route from South Auckland to the North Shore. More>>

ALSO:

Media Mega Merger: Full Steam Ahead For Appeal

New Zealand's two largest news publishers have confirmed they are committed to pursuing their appeal against the Commerce Commission's rejection of the proposal to merge their operations. More>>

Crown Accounts: $4.1 Billion Surplus

The New Zealand Government has achieved its third fiscal surplus in a row with the Crown accounts for the year ended 30 June 2017 showing an OBEGAL surplus of $4.1 billion, $2.2 billion stronger than last year, Finance Minister Steven Joyce says. More>>

ALSO:

Mycoplasma Bovis: One New Property Tests Positive

The newly identified property... was already under a Restricted Place notice under the Biosecurity Act. More>>

Accounting Scandal: Suspension Of Fuji Xerox From All-Of-Government Contract

General Manager of New Zealand Government Procurement John Ivil says, “FXNZ has been formally suspended from the Print Technology and Associated Services (PTAS) contract and terminated from the Office Supplies contract.” More>>